Argentina and Mexico announce production of the Corona vaccine for Latin American countries

Argentine President Alberto Fernandez announced on Wednesday that Argentina and Mexico will take over the production of the future vaccine against the Corona virus, which is being developed by the "AstraZeneca" laboratory with the University of Oxford in Britain, indicating that the two countries will also work to distribute it in Latin American countries, with the exception of Brazil.

During a press conference, the president said, "The AstraZeneca laboratory has signed an agreement with the (Carlos) Slim Foundation to produce between 150 and 250 million vaccines for all of Latin America, except for Brazil." These vaccines "will be available in the first half of 2021 and will be distributed equitably between countries." At the request of governments. "

He added that "Latin American production will be undertaken by Argentina and Mexico, and this will allow (the vaccine) to reach all countries of the region in a fast and effective manner."

The Argentine president pointed out that the agreement concluded between the laboratory "AstraZeneca" and the "Carlos Slim" foundation, which will finance the production, "provides access to reasonable prices", ranging between 3 and 4 dollars for the vaccine, and "this is very important for Latin America because it allows all our countries" to obtain On the vaccine, Fernandes said.

And the "AstraZeneca" office in Mexico confirmed in a statement that the production of the vaccine would be "without economic benefit" for the laboratory.

Follow our latest local and sports news and the latest political and economic developments via Google news